254 related articles for article (PubMed ID: 9252326)
1. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.
Jentsch JD; Redmond DE; Elsworth JD; Taylor JR; Youngren KD; Roth RH
Science; 1997 Aug; 277(5328):953-5. PubMed ID: 9252326
[TBL] [Abstract][Full Text] [Related]
2. Schizophrenia clues from monkeys.
Pennisi E
Science; 1997 Aug; 277(5328):900. PubMed ID: 9281070
[No Abstract] [Full Text] [Related]
3. Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex.
Elsworth JD; Groman SM; Jentsch JD; Leranth C; Redmond DE; Kim JD; Diano S; Roth RH
Int J Neuropsychopharmacol; 2014 Oct; 18(6):. PubMed ID: 25522392
[TBL] [Abstract][Full Text] [Related]
4. Clozapine normalizes prefrontal cortex dopamine transmission in monkeys subchronically exposed to phencyclidine.
Elsworth JD; Jentsch JD; Morrow BA; Redmond DE; Roth RH
Neuropsychopharmacology; 2008 Feb; 33(3):491-6. PubMed ID: 17507917
[TBL] [Abstract][Full Text] [Related]
5. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.
Jentsch JD; Tran A; Le D; Youngren KD; Roth RH
Neuropsychopharmacology; 1997 Aug; 17(2):92-9. PubMed ID: 9252984
[TBL] [Abstract][Full Text] [Related]
6. Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits.
Jentsch JD; Taylor JR; Elsworth JD; Redmond DE; Roth RH
Neuroscience; 1999 Mar; 90(3):823-32. PubMed ID: 10218783
[TBL] [Abstract][Full Text] [Related]
7. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs.
Cochran SM; Kennedy M; McKerchar CE; Steward LJ; Pratt JA; Morris BJ
Neuropsychopharmacology; 2003 Feb; 28(2):265-75. PubMed ID: 12589379
[TBL] [Abstract][Full Text] [Related]
8. Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.
Dunn MJ; Killcross S
Behav Brain Res; 2006 Dec; 175(2):271-7. PubMed ID: 17027093
[TBL] [Abstract][Full Text] [Related]
9. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats.
Jentsch JD; Dazzi L; Chhatwal JP; Verrico CD; Roth RH
Neurosci Lett; 1998 Dec; 258(3):175-8. PubMed ID: 9885959
[TBL] [Abstract][Full Text] [Related]
10. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.
Linn GS; Negi SS; Gerum SV; Javitt DC
Psychopharmacology (Berl); 2003 Sep; 169(3-4):234-9. PubMed ID: 12845408
[TBL] [Abstract][Full Text] [Related]
11. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.
Balla A; Sershen H; Serra M; Koneru R; Javitt DC
Neuropsychopharmacology; 2003 Jan; 28(1):34-44. PubMed ID: 12496938
[TBL] [Abstract][Full Text] [Related]
12. M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice.
Wang RY; Liang X
Neuropsychopharmacology; 1998 Jul; 19(1):74-85. PubMed ID: 9608579
[TBL] [Abstract][Full Text] [Related]
13. Clozapine ameliorates epigenetic and behavioral abnormalities induced by phencyclidine through activation of dopamine D1 receptor.
Aoyama Y; Mouri A; Toriumi K; Koseki T; Narusawa S; Ikawa N; Mamiya T; Nagai T; Yamada K; Nabeshima T
Int J Neuropsychopharmacol; 2014 May; 17(5):723-37. PubMed ID: 24345457
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine.
Kargieman L; Santana N; Mengod G; Celada P; Artigas F
Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14843-8. PubMed ID: 17785415
[TBL] [Abstract][Full Text] [Related]
15. Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration.
Elsworth JD; Groman SM; Jentsch JD; Valles R; Shahid M; Wong E; Marston H; Roth RH
Neuropharmacology; 2012 Mar; 62(3):1442-52. PubMed ID: 21875607
[TBL] [Abstract][Full Text] [Related]
16. Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment.
Amitai N; Markou A
Pharmacol Biochem Behav; 2009 Sep; 93(3):248-57. PubMed ID: 18809428
[TBL] [Abstract][Full Text] [Related]
17. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
Arvanov VL; Wang RY
J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
Umino A; Takahashi K; Nishikawa T
Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
[TBL] [Abstract][Full Text] [Related]
19. Dopamine dysregulation in the prefrontal cortex relates to cognitive deficits in the sub-chronic PCP-model for schizophrenia: A preliminary investigation.
McLean SL; Harte MK; Neill JC; Young AM
J Psychopharmacol; 2017 Jun; 31(6):660-666. PubMed ID: 28441905
[TBL] [Abstract][Full Text] [Related]
20. Disruption of medial prefrontal synchrony in the subchronic phencyclidine model of schizophrenia in rats.
Young AM; Stubbendorff C; Valencia M; Gerdjikov TV
Neuroscience; 2015 Feb; 287():157-63. PubMed ID: 25542422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
